ID   BT054
AC   CVCL_N707
SY   BT54
DR   ATCC; CRL-3416
DR   cancercelllines; CVCL_N707
DR   Wikidata; Q54798483
RX   PubMed=20388696;
RX   PubMed=30153289;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (PubMed=20388696).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-3416
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C4326; Anaplastic oligodendroglioma
DI   ORDO; Orphanet_251630; Anaplastic oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
RX   PubMed=20388696; DOI=10.1093/neuonc/noq031; PMCID=PMC2940664;
RA   Kelly J.J.P., Blough M.D., Stechishin O.D.M., Chan J.A.-W.,
RA   Beauchamp D.C., Perizzolo M., Demetrick D.J., Steele L., Auer R.N.,
RA   Hader W.J., Westgate M.R., Parney I.F., Jenkins R.B., Cairncross J.G.,
RA   Weiss S.;
RT   "Oligodendroglioma cell lines containing t(1;19)(q10;p10).";
RL   Neuro-oncol. 12:745-755(2010).
//
RX   PubMed=30153289; DOI=10.1371/journal.pone.0202860; PMCID=PMC6112648;
RA   Yuan A.L., Ricks C.B., Bohm A.K., Lun X.-Q., Maxwell L., Safdar S.,
RA   Bukhari S., Gerber A., Sayeed W., Bering E.A., Pedersen H.,
RA   Chan J.A.-W., Shen Y.-Q., Marra M.A., Kaplan D.R., Mason W.P., Goodman L.D.,
RA   Ezhilarasan R., Kaufmann A.B., Cabral M., Robbins S.M., Senger D.L.,
RA   Cahill D.P., Sulman E.P., Cairncross J.G., Blough M.D.;
RT   "ABT-888 restores sensitivity in temozolomide resistant glioma cells
RT   and xenografts.";
RL   PLoS ONE 13:e0202860.1-e0202860.18(2018).
//